UNIVERSITY OF OKLAHOMA
Federal contract awards won by UNIVERSITY OF OKLAHOMA (UEI GY8NMUZQXVS7), 2016–2026 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
36
awards
$185,477,355
total value
2
agencies
Agencies buying from UNIVERSITY OF OKLAHOMA
What UNIVERSITY OF OKLAHOMA sells
541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) (16)541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) (9)325412 — PHARMACEUTICAL PREPARATION MANUFACTURING (6)611310 — COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS (2)621320 — OFFICES OF OPTOMETRISTS (1)
Awards
RADIOPHARMACEUTICALS EO 14398
Department of Veterans Affairs · $444,361 · Oct 1, 2026
STRONG HEART STUDY (SHS) - UNIVERSITY OF OKLAHOMA, FIELD CENTER (FC), TASK AREA C: DATA BOOK
Department of Health and Human Services · $469,049 · Jan 12, 2026
RADIOPHARMACEUTICALS FOR MUS
Department of Veterans Affairs · $444,488 · Oct 1, 2025
RADIOPHARMACEUTICALS
Department of Veterans Affairs · $435,690 · Oct 1, 2025
BASE IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS TASK ORDER TITLE: FURTHER DEVELOPMENT OF MITOCHONDRIA-TARGETED HONOKIOL FOR PREVENTION OF LUNG CANCER: ADENOCARCINOMA A
Department of Health and Human Services · $1,234,179 · Sep 25, 2025
RADIOPHARMACEUTICALS
Department of Veterans Affairs · $423,950 · Oct 1, 2024
TO TITLE: A NOVEL MRNA VACCINE TO PREVENT TRIPLE NEGATIVE BREAST CANCER IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS
Department of Health and Human Services · $764,880 · Jun 17, 2024
STRONG HEART STUDY (SHS)- UNIVERSITY OF OKLAHOMA-FIELD CENTER (FC), TASK AREA B.3, YEAR 3
Department of Health and Human Services · $333,373 · Feb 15, 2024
PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
Department of Health and Human Services · $149,995,000 · Jan 25, 2024
STRONG HEART STUDY (SHS)- COORDINATING CENTER (CC)- TASK AREA B.2.
Department of Health and Human Services · $1,332,779 · Nov 1, 2023
RADIOPHARMACEUTICALS
Department of Veterans Affairs · $465,458 · Oct 1, 2023
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS TASK ORDER TITLE: COLORECTAL CANCER (CRC) PREVENTION BY TPST-1495 IN PIRC RAT MODEL
Department of Health and Human Services · $1,140,397 · Sep 11, 2023
STRONG HEART STUDY (SHS)- OKLAHOMA UNIVERSITY HEALTH CENTER (OUHSC) COORDINATING CENTER(CC) SUBTASK B.2 - PHASE VII EXAM AND EXAM CLOSEOUT.
Department of Health and Human Services · $1,270,801 · Nov 1, 2022
SHS OUHSC FC SUBTASK AREA B.2 PHASE VII EXAM AND EXAM CLOSEOUT.
Department of Health and Human Services · $678,572 · Nov 1, 2022
RADIOPHARMACEUTICALS
Department of Veterans Affairs · $411,118 · Oct 1, 2022
RADIOPHARMACEUTICALS
Department of Veterans Affairs · $2,126,843 · Oct 1, 2022
CHEMOPREVENTION WITH MITOCHONDRIA-TARGETED HONOKIOL IN MOUSE MODELS OF LUNG CANCER: ADENOCARCINOMA AND SQUAMOUS CELL CARCINOMA
Department of Health and Human Services · $1,201,554 · Sep 15, 2022
TASK ORDER TITLE: PREVENTING LUNG ADENOCARCINOMA (LUAD) USING TRAIL INDUCING AGENT, ONC201 BASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS
Department of Health and Human Services · $982,258 · Sep 8, 2022
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
Department of Health and Human Services · $1,046,094 · Aug 5, 2022
INTERVENTIONAL RADIOLOGY SERVICES
Department of Veterans Affairs · $489,983 · Oct 1, 2021
RADIOPHARMACEUTICALS
Department of Veterans Affairs · $357,000 · Oct 1, 2021
PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM - A NOVEL MULTI-ANTIGEN VACCINE (TNBCVAX) TO PREVENT TRIPLE NEGATIVE BREAST CANCER
Department of Health and Human Services · $1,113,527 · Sep 16, 2021
PROJECT TITLE: FURTHER EVALUATION OF AMHR2-ED ANTIGENS FOR EPITHELIAL OVARIAN CARCINOMA
Department of Health and Human Services · $1,029,991 · Sep 15, 2021
PREVENT EFFICACY POOL: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
Department of Health and Human Services · $911,531 · May 24, 2021
STRONG HEART STUDY (SHS): OUHSC FIELD CENTER - TASK AREA B.1 AND B.3
Department of Health and Human Services · $438,923 · Apr 30, 2021
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids